We recently showed that clones of Th1 cells, but not Th2 cells, expressed a functional beta-2-adrenergic receptor (β 2 AR) and that either norepinephrine or the β 2 AR agonist terbutaline stimulated this receptor to modulate the level of Th1 cytokines produced. In the present study, we show that norepinephrine and terbutaline stimulate the β 2 AR to decrease the level of IL-2 produced by freshly isolated murine splenic naive CD4 ϩ T cells from either Balb/C or DO11.10 transgenic mice and activated polyclonally with anti-CD3 and anti-CD28 mAbs. In contrast, the level of cytokines produced by primary effector Th1 and Th2 cells were unaffected when norepinephrine, terbutaline, or cAMP analogs were added at the time of restimulation. These results suggest that a diversity exists among CD4 ϩ Tcell subsets with respect to the level of adrenergic receptor expression, responsiveness to cAMP, stage of cell differentiation, or a combination of the above.
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INTRODUCTION
A number of findings provide evidence for a bidirectional and integrated relationship between the neuroendocrine and immune systems (Madden, Sanders, & Felten, 1995) . First, cells of the neuroendocrine and immune systems share a number of similar receptors for neurotransmitters, neuropeptides, hormones, and cytokines. Second, both immune and neuroendocrine cells produce cytokines and peptide hormones. Third, nerve fibers containing both neurotransmitters and neuropeptides are found in specific lymphoid tissue compartments where they directly contact lymphocytes. Fourth, immune function is affected by the stimulation or destruction of neuroendocrine tissues in vivo, while neuroendocrine cell function is affected by an ongoing immune response. And finally, immune and neuroendocrine cell functions are affected by the exogenous addition of neurotransmitters, neuropeptides, hormones, and cytokines in vitro. These findings strongly suggest that an autoregulatory loop exists between these systems to maintain their ability to function normally. Therefore, if neurotransmitters and the receptors that respond to the neurotransmitters affect the magnitude of immune cell activity, then an environmental agent that targets either the production and/or release of neurotransmitters or the level of receptor expression on immune cells can affect immune system function indirectly.
